ISLET is a European project spearheaded by a unique team of scientists that share an ambitious common goal: to pioneer a new advanced cell therapy for Type 1 Diabetes. This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 874839 ISLET.